The definition, diagnosis and management of mild hemophilia A: communication from the SSC of the ISTH
The definition, diagnosis and management of mild hemophilia A: communication from the SSC of the ISTH
复制标题
DOI:
10.1111/jth.14315
复制
发表时间:
2018-12-01
影响因子:
10.4
通讯作者:
Fijnvandraat, K.
中科院分区:
文献类型:
--
作者:
Makris, M.;Oldenburg, J.;Fijnvandraat, K.
At first sight the diagnosis of hemophilia A is obvious and is defined as a deficiency of factor VIII activity. The internationally accepted definition from the International Society of Thrombosis and Haemostasis (ISTH) has served us well, especially in separating severe from nonsevere hemophilia [1]. This international definition considers mild hemophilia A to have FVIII: C> 5 IU dL À1 and< 40 IU dLÀ1 without specifying the type of assay to be used [1]. At the upper end, however, the situation is not so easy or clear because many mutations can result in a dysfunctional molecule and the different FVIII assays may yield different FVIII: C results [2]. Additional complexity arises from day to day variability in FVIII: C, from the increase in FVIII with age, inflammation and also the increase as a result of the acute phase response [3], resulting in different inter-and intra-individual factor levels even among patients with the same F8 genotype [4]. Some patients can bleed more than normal with FVIII: C levels that are higher than 40 IU dL À1 (ie 0.4 IU mL À1)[5]. Within families, blood group differences can partially account for some of the variation in FVIII: C level. Although we believe the initial ISTH definition should be maintained, it should be modified in accordance with the following proposals.